The spinout has turned to Stanford-Start X Fund as it prepares to add data sciences, engineering and clinical features to its machine-learning based service for health insurers.

Existing investor Merck & Co took part in a round that boosted the healthcare work management platform's overall funding to $135m.

Fusion Pharmaceuticals has closed its series A round at $46m following a $21m extension that featured medical device maker Varian Medical Systems.

The list includes spinouts aiming to tackle arthritis, cognitive disabilities and diseases of citrus plants.

The cancer treatment developer spun out from UCL has secured $80m in series C capital from investors including Woodford Investment Management and Syncona.

Khosla Ventures led the genetic medicine developer's series A round, which comes after a 2015 seed round featuring Bloomberg Beta.

Pharmascience subsidiary Pendopharm has participated in Edesa Biotech's series A round as part of a licensing agreement.

Acute Care Solutions has participated in a $30.8m round for home care access platform DispatchHealth that was co-led by Questa Capital and Alta Partners.